Chikusetsusaponin IVCAS# 7518-22-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 7518-22-1 | SDF | Download SDF |
PubChem ID | 197091 | Appearance | White powder |
Formula | C47H74O18 | M.Wt | 927.08 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Synonyms | Chikusetsusaponin IV; Oleanoside E | ||
Solubility | Soluble in acetonitrile and methanol; insoluble in water | ||
Chemical Name | (2S,3S,4R,5R,6S)-6-[[(6aR,6bS,8aS,12aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid | ||
SMILES | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(O7)CO)O)O)O)O)C)C)C2C1)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C | ||
Standard InChIKey | KQSFNXMDCOFFGW-UGBTYEQWSA-N | ||
Standard InChI | InChI=1S/C47H74O18/c1-42(2)14-16-47(41(59)65-39-33(55)30(52)28(50)23(19-48)61-39)17-15-45(6)21(22(47)18-42)8-9-26-44(5)12-11-27(43(3,4)25(44)10-13-46(26,45)7)62-40-34(56)31(53)35(36(64-40)37(57)58)63-38-32(54)29(51)24(20-49)60-38/h8,22-36,38-40,48-56H,9-20H2,1-7H3,(H,57,58)/t22-,23-,24+,25?,26?,27?,28-,29+,30+,31-,32-,33-,34-,35+,36+,38+,39+,40+,44+,45-,46-,47+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Chikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway. |
Chikusetsusaponin IV Dilution Calculator
Chikusetsusaponin IV Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.0787 mL | 5.3933 mL | 10.7866 mL | 21.5731 mL | 26.9664 mL |
5 mM | 0.2157 mL | 1.0787 mL | 2.1573 mL | 4.3146 mL | 5.3933 mL |
10 mM | 0.1079 mL | 0.5393 mL | 1.0787 mL | 2.1573 mL | 2.6966 mL |
50 mM | 0.0216 mL | 0.1079 mL | 0.2157 mL | 0.4315 mL | 0.5393 mL |
100 mM | 0.0108 mL | 0.0539 mL | 0.1079 mL | 0.2157 mL | 0.2697 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- H-Leu-OMe.HCl
Catalog No.:BCC2973
CAS No.:7517-19-3
- PRE-084 hydrochloride
Catalog No.:BCC6708
CAS No.:75136-54-8
- 2-Acetamido-2-deoxy-D-glucose
Catalog No.:BCC8508
CAS No.:7512-17-6
- Obacunone
Catalog No.:BCN4303
CAS No.:751-03-1
- 2',6'-Dihydroxy-4'-methoxyacetophenone
Catalog No.:BCN6891
CAS No.:7507-89-3
- 20,24-Dihydroxydammar-25-en-3-one
Catalog No.:BCN4302
CAS No.:75069-59-9
- Daphnilongeranin C
Catalog No.:BCN4301
CAS No.:750649-07-1
- 1,2-Cyclohexanedicarboximide
Catalog No.:BCC8416
CAS No.:7506-66-3
- Ethylamine
Catalog No.:BCN1799
CAS No.:75-04-7
- 9-Methoxycanthin-6-one
Catalog No.:BCN2993
CAS No.:74991-91-6
- Callimorphine
Catalog No.:BCN1959
CAS No.:74991-73-4
- JSH-23
Catalog No.:BCC4610
CAS No.:749886-87-1
- 3,6-Bis(hydroxymethyl)durene
Catalog No.:BCC8598
CAS No.:7522-62-5
- TAK-700 R-form
Catalog No.:BCC4203
CAS No.:752243-39-3
- Ophiopogonanone A
Catalog No.:BCN6630
CAS No.:75239-63-3
- H-Phe-OMe.HCl
Catalog No.:BCC3009
CAS No.:7524-50-7
- H-Trp-OMe.HCl
Catalog No.:BCC3114
CAS No.:7524-52-9
- Nemonapride
Catalog No.:BCC7165
CAS No.:75272-39-8
- HEPES Sodium salt
Catalog No.:BCC7591
CAS No.:75277-39-3
- Kukoamine A
Catalog No.:BCN3835
CAS No.:75288-96-9
- H-Pro-NH2
Catalog No.:BCC3018
CAS No.:7531-52-4
- H-Leucinol
Catalog No.:BCC2725
CAS No.:7533-40-6
- Lovastatin
Catalog No.:BCN1060
CAS No.:75330-75-5
- Indacaterol Maleate
Catalog No.:BCC4358
CAS No.:753498-25-8
Suppression of Fas-mediated apoptosis of keratinocyte cells by chikusetsusaponins isolated from the roots of Panax japonicus.[Pubmed:16534721]
Planta Med. 2006 Feb;72(3):193-8.
Fas-mediated apoptotic cell death of a human keratinocyte cell line, HaCaT cells, and of a murine keratinocyte cell line, Pam212 cells, was suppressed by pre-treatment with a methanol extract from the roots of Panax japonicus C.A. Meyer. Activity-guided fractionation led to the isolation of chikusetsusaponins IV, IVa, V and polysciasaponin P5 as the active ingredients. Of these compounds, Chikusetsusaponin IV, was most active when applied at a concentration of 12.5 microg/mL. The intracellular hallmark events of apoptosis such as DNA fragmentation and chromatin condensation were significantly reduced by the treatment with Chikusetsusaponin IV. The apoptotic cell death of Jurkat cells was also suppressed by treatment with the active saponins. These results suggest that the use of chikusetsusaponins IV, IVa, V, polysciasaponin P5, or a crude extract of P. japonicus containing these saponins is expected to relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.